실제로 임상 2상부터는 LO나 공동개발을 생각하고 있는 것으로 보입니다...
Thrilled to represent #siRNAgen Therapeutics at BIO-Europe 2025 (November 3-5) — where the future of RNAi therapeutics takes center stage!
We developed the #SAMiRNA® platform enabling safe and efficient RNAi delivery beyond the liver—reaching organs like the lung, brain, and immune cells. This breakthrough opens new frontiers in oncology, immunology, and fibrosis.
We are actively seeking strategic partnerships to accelerate the global impact of this platform. Key opportunities include:
🧬 SRN-001 (IPF & Beyond): Licensing/co-development for Phase 2 entry. Also targeting cancer and obesity.
💇 CosmeRNA® Global Expansion: Securing distribution/licensing partners for our innovative RNA-based hair care solution.
🏭 CDMO/CRO Services: Providing end-to end RNAi development support and specialized in vivo studies.
Join my presentation:
🗓 Nov 3, 17:00 CET
📍 Presentation Theater 1
🎤 “Revolutionizing RNAi with SAMiRNA”